DeepUll showcased its UllCore platform and UllCore BSI Test, a one-hour multiplex PCR assay targeting 95 percent of ...

UllCORE is designed to transform life-saving clinical decision making for sepsis patients Barcelona, Spain – 25 April 2024 – deepull, a medical diagnostics company developing culture-free diagnostic ...

"Deepull debuts point of care sepsis detection UllCORE system" was originally created and published by Medical Device Network ...

Kimberle Chapin, MD, as Chief Medical Officer and Wade Stevenson as Chief Marketing and Sales OfficerKimberle Chapin brings ...

Revenue of $922.1 million, decreased 3% year-over-year Net income attributable to ChampionX of $112.9 million, increased 78% year-over-year Adjusted net income of $96.4 million, increased 17% ...

Procter & Gamble (PG) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

deepull unveils 1 hour, direct-from-blood multiplex PCR test for 95% of sepsis-causing pathogens at ESCMID 2024 Barcelona, Spain – 25 April 2024 – deepull, a medical diagnostics company ...

Jordi Carrera, Chief Executive Officer and Co-Founder of deepull, said: “Kim and Wade are joining at an important time for the business as it progresses its automated sepsis diagnostic test.

Barcelona, Spain – 25 April 2024 – deepull, a medical diagnostics company developing culture-free diagnostic solutions for rapid pathogen identification for sepsis and other acute infections ...

deepull appoints Kimberle Chapin, MD, as Chief Medical Officer and Wade Stevenson as Chief Marketing and Sales Officer Barcelona, Spain – 18 April 2024 – deepull, a medical diagnostics company ...

deepull unveils 1 hour, direct-from-blood multiplex PCR test for 95% of sepsis-causing pathogens at ESCMID 2024 Barcelona, Spain – 25 April 2024 – deepull, a medical diagnostics company developing ...